Clinical Trial Update: Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial at St. Jude Children's Research Hospital determined a safe dose of the ultrasound contrast agent Optison in pediatric patients with abdominal or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Neoplasms
• Pelvic Neoplasms

Drugs mentioned

• Optison

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Abdominal Neoplasms, Pelvic Neoplasms | Phase 1 | Status: COMPLETED